ATC Group: B02BD13 Coagulation factor X

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B02BD13 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B02 Antihemorrhagics
3 B02B Vitamin K and other hemostatics
4 B02BD Blood coagulation factors
5 B02BD13

Active ingredients in B02BD13

Active Ingredient

Coagulation factor X is derived from human plasma and used as a replacement for the naturally existing coagulation factor X in patients with hereditary factor X deficiency.

Related product monographs

Document Type Information Source  
 COAGADEX Powder and solvent for solution for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicines in this ATC group

Austria (AT)

Croatia (HR)

Estonia (EE)

Ireland (IE)

Lithuania (LT)

Poland (PL)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.